184 related articles for article (PubMed ID: 8941397)
1. 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.
Gershonov E; Granoth R; Tzehoval E; Gaoni Y; Fridkin M
J Med Chem; 1996 Nov; 39(24):4833-43. PubMed ID: 8941397
[TBL] [Abstract][Full Text] [Related]
2. Tuftsin: its chemistry, biology, and clinical potential.
Fridkin M; Najjar VA
Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and immunomodulatory activity of [60]fullerene-tuftsin conjugates.
Xu Y; Zhu J; Xiang K; Li Y; Sun R; Ma J; Sun H; Liu Y
Biomaterials; 2011 Dec; 32(36):9940-9. PubMed ID: 21937103
[TBL] [Abstract][Full Text] [Related]
4. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
Mezö G; Szekerke M; Sármay G; Gergely J
Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric identification of the trypsin cleavage pathway in lysyl-proline containing oligotuftsin peptides.
Manea M; Mezo G; Hudecz F; Przybylski M
J Pept Sci; 2007 Apr; 13(4):227-36. PubMed ID: 17394121
[TBL] [Abstract][Full Text] [Related]
8. [Macrophage activation by synthetic peptides. I. Kinetic changes in the transport of fluorescein anions across the plasma membrane of macrophages].
Gamaleĭ Ia; Kaulin AB; Kirpichnikova KM
Tsitologiia; 1989 Sep; 31(9):1050-7. PubMed ID: 2623768
[TBL] [Abstract][Full Text] [Related]
9. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
Fridkin M; Tsubery H; Tzehoval E; Vonsover A; Biondi L; Filira F; Rocchi R
J Pept Sci; 2005 Jan; 11(1):37-44. PubMed ID: 15635725
[TBL] [Abstract][Full Text] [Related]
10. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
Nishioka K; Obeyesekere NU; McMurray JS
Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
[TBL] [Abstract][Full Text] [Related]
11. Further investigations on the antinociceptive activity of tuftsin analogs.
Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
[TBL] [Abstract][Full Text] [Related]
12. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of tuftsin, its analogue and conjugates containing muramyl dipeptides or nor-muramyl dipeptides.
Dzierzbicka K; Trzonkowski P; Sewerynek P; Kolodziejczyk AM; Myśliwski A
J Pept Sci; 2005 Mar; 11(3):123-35. PubMed ID: 15635647
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive activity of analogs of tripeptide Lys-Arg-Pro with D-amino acid residues.
Siemion IZ; Kluczyk A; Słoń JJ; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1994; 42(3):205-7. PubMed ID: 7487354
[TBL] [Abstract][Full Text] [Related]
15. Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitro.
Spirer Z; Zakuth V; Tzehoval E; Dagan S; Fridkin M; Golander A; Melamed I
J Clin Lab Immunol; 1989 Jan; 28(1):27-31. PubMed ID: 2786082
[TBL] [Abstract][Full Text] [Related]
16. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
Paradowski A; Dynowski Z; Kubik A; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
[TBL] [Abstract][Full Text] [Related]
17. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
[TBL] [Abstract][Full Text] [Related]
18. The evidence on the possible interleukin-1 alpha tuftsin competition.
Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
[TBL] [Abstract][Full Text] [Related]
20. Solution conformation of a potent cyclic analogue of tuftsin: low- temperature nuclear magnetic resonance study in a cryoprotective mixture.
D'Ursi A; Albrizio S; Fattorusso C; Lavecchia A; Zanotti G; Temussi PA
J Med Chem; 1999 May; 42(10):1705-13. PubMed ID: 10346923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
